Table 1.

Demographic and follow-up characteristics of 175 patients with sarcoidosis and 18F-FDG PET/CT evaluation

CharacteristicsTotal (N = 175)Metabolic bone involvement (n = 32)No metabolic bone involvement (n = 143)
Gender (male), n (%)91 (52)14 (44)77 (54)
Age at diagnosis (years), mean (s.d.)42 (14)46 (15)41 (14)
18F-FDG PET/CT exams, n, mean (s.d.)2.3 (1.9)3.1 (2.6)2.1 (1.6)
Follow-upa, years, mean (s.d.)8.5 (7.4)8.4 (6.6)8.6 (7.6)
CharacteristicsTotal (N = 175)Metabolic bone involvement (n = 32)No metabolic bone involvement (n = 143)
Gender (male), n (%)91 (52)14 (44)77 (54)
Age at diagnosis (years), mean (s.d.)42 (14)46 (15)41 (14)
18F-FDG PET/CT exams, n, mean (s.d.)2.3 (1.9)3.1 (2.6)2.1 (1.6)
Follow-upa, years, mean (s.d.)8.5 (7.4)8.4 (6.6)8.6 (7.6)
a

Follow-up refers to the time from diagnosis to the last medical visit.

Table 1.

Demographic and follow-up characteristics of 175 patients with sarcoidosis and 18F-FDG PET/CT evaluation

CharacteristicsTotal (N = 175)Metabolic bone involvement (n = 32)No metabolic bone involvement (n = 143)
Gender (male), n (%)91 (52)14 (44)77 (54)
Age at diagnosis (years), mean (s.d.)42 (14)46 (15)41 (14)
18F-FDG PET/CT exams, n, mean (s.d.)2.3 (1.9)3.1 (2.6)2.1 (1.6)
Follow-upa, years, mean (s.d.)8.5 (7.4)8.4 (6.6)8.6 (7.6)
CharacteristicsTotal (N = 175)Metabolic bone involvement (n = 32)No metabolic bone involvement (n = 143)
Gender (male), n (%)91 (52)14 (44)77 (54)
Age at diagnosis (years), mean (s.d.)42 (14)46 (15)41 (14)
18F-FDG PET/CT exams, n, mean (s.d.)2.3 (1.9)3.1 (2.6)2.1 (1.6)
Follow-upa, years, mean (s.d.)8.5 (7.4)8.4 (6.6)8.6 (7.6)
a

Follow-up refers to the time from diagnosis to the last medical visit.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close